HCPCS Code Descriptor:
Injection, mepolizumab, 1 mg
00173-0904-42, 00173-0892-42, 00173-0892-01, 00173-0881-01
Route of Administration:
NUCALA is an Anti-Eosinophil Asthma drug manufactured by GSK and administered via the Subcutaneous route of administration. The J Code: J2182 is aligned to the drug NUCALA.